Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies. What are the biggest investment lessons ...
Johannes Fruehauf, co-founder of LabCentral, interviews four biotech startup executives about their coronavirus response.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
Henry Li, Sorrento's co-founder, director, president and chief executive officer, did a follow-up interview with BioSpace to discuss the news and speculation surrounding it.
The U.S. Biomedical Advanced Research and Development Authority (BARDA) paid more than $1 billion to support the development, production and delivery of the vaccine beginning this fall.
Funding to Accelerate Development of INSPECTR™ Rapid Diagnostic Platform to Improve Testing in At-home and Low-resource Settings